Benoit Gourdier is a seasoned executive with over 25 years of experience in the life sciences and biopharmaceutical industries. Holding a Master's degree in Chemical Engineering from École Polytechnique in France and an MBA from INSEAD, Gourdier began his career at Sanofi, where he spearheaded process optimization initiatives that reduced manufacturing costs by 30% across multiple drug production lines. He later advanced to leadership roles at Lonza, managing global bioprocessing operations and scaling up production for blockbuster biologics, including monoclonal antibodies and cell therapies. Throughout his career, Gourdier has been recognized for his innovative approaches to sustainable manufacturing and supply chain resilience. Notable achievements include leading the development of single-use bioreactor technologies at Cytiva, which accelerated time-to-market for client therapies by up to 40%, and implementing digital twin simulations at Merck that enhanced yield predictions and minimized waste. His strategic foresight during the COVID-19 pandemic ensured uninterrupted supply of critical reagents, earning him the industry's BioProcess International Award for Excellence in 2021. As Executive Vice President of Bioscience Production at AVANTOR INC., Gourdier oversees the company's global bioscience manufacturing operations, driving efficiency, innovation, and compliance in high-growth areas like gene and cell therapies. Under his leadership, Avantor has expanded its production capacity by 50% in key facilities, forging partnerships with leading biotech firms and positioning the company as a premier provider of mission-critical materials for advanced therapeutics.